Criteria Capital Risc | Criteria Bio Ventures and Criteria Venture Tech

vc$300MCo-investsLeads rounds

◆ Fund Size

$300M

◆ Check Size

$0.5M→$5.0M

◆ Location

Spain

◆ Portfolio

3 companies

◆ Activity

Statusactively investing

◆ Links

Website ↗

◆ Investment Thesis

Invests in early-stage biotechnology, healthcare, and technology companies, with emphasis on transformative B2B SaaS, deep tech, software infrastructure, data, IoT, insurtech, cybersecurity, and life sciences.

◆ About Criteria Capital Risc

Two specialized investment vehicles under Criteria Capital Risc focused on BioTech/health and DeepTech respectively. Plans to invest €300 million in early-stage companies primarily in Spain and Portugal with selective investments in Europe and North America.

◆ Sectors

BiotechDigital HealthCybersecuritySemiconductors

◆ Stages

pre-seedseedseries-a

◆ Geography Focus

EuropeNorth AmericaPortugalSpain

◆ Team

Name	Title	Role	Links
Marcelino Armenter	Chairman	senior
Pablo Cironi, PhD	Director Investment	—

◆ Notable Investments

8LayersCytospire TherapeuticsAdaptam TherapeuticsNRG TherapeuticsMinoryx TherapeuticsAboleris PharmaTolerance BioNanusensMinoryx

◆ Traits

Leads rounds

Co-invests

◆ FAQ

What does Criteria Bio Ventures and Criteria Venture Tech invest in?

Criteria Bio Ventures and Criteria Venture Tech invests in Biotech, Digital Health, Cybersecurity and Semiconductors at the pre-seed, seed and series-a stages.

Which geographies does Criteria Bio Ventures and Criteria Venture Tech focus on?

Criteria Bio Ventures and Criteria Venture Tech focuses on Europe, North America, Portugal and Spain, and is headquartered in Spain.

What is Criteria Bio Ventures and Criteria Venture Tech's typical check size?

Criteria Bio Ventures and Criteria Venture Tech typically writes checks of $0.5M to $5M.